BioMedNewsBreaks — Safety Shot (NASDAQ: SHOT), Mr. Checkout Announce Partnership to Expand Nationwide Distribution through Independent Retailers

June 4, 2024 10:47:54

Safety Shot (NASDAQ: SHOT), a wellness and dietary supplement company, is expanding its distribution footprint through a strategic partnership with Mr. Checkout, a national network of independent distributors, full-line grocery distributors and wagon-jobbers. Calling the collaboration a “significant milestone” in the company’s mission to provide a revolutionary solution for responsible alcohol consumption to the masses, the company noted that the partnership will help to introduce Safety Shot to consumers through convenience stores, neighborhood markets and independent grocers across the country. With an impressive track record of launching, scaling and promoting innovative products in the retail space, Mr. Checkout has built an extensive distribution network comprised of more than 200,000 independent retail locations across the country. Carefully formulated with essential B vitamins, antioxidants, electrolytes, and nootropics, Safety Shot is the world’s first beverage to reduce blood alcohol content by supporting its metabolism in as little as 30 minutes. “We are thrilled to partner with Mr. Checkout and leverage their extensive distribution network to bring Safety Shot to a wider, diversified audience,” said Safety Shot chief revenue officer Josh Wagner in the press release. “This partnership is a significant step forward in exploring new verticals of accessibility to our revolutionary product. We are confident that with Mr. Checkout’s support, we will be able to expand Safety Shot’s presence into diversified retailers to meet our customers where they prefer to shop.”

To view the full press release, visit https://ibn.fm/AJgaQ

About Safety Shot Inc.

Safety Shot, a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while also boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants and bars throughout 2024. For more information about the company, visit www.SafetyShotHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to SHOT are available in the company’s newsroom at https://ibn.fm/SHOT

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is powered by IBN